These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 2193578

  • 1. Metabolic responses to cachectin/TNF. A brief review.
    Tracey KJ, Cerami A.
    Ann N Y Acad Sci; 1990; 587():325-31. PubMed ID: 2193578
    [Abstract] [Full Text] [Related]

  • 2. Cachectin: a hormone that triggers acute shock and chronic cachexia.
    Tracey KJ, Lowry SF, Cerami A.
    J Infect Dis; 1988 Mar; 157(3):413-20. PubMed ID: 3278061
    [Abstract] [Full Text] [Related]

  • 3. Studies of cachexia in parasitic infection.
    Tracey KJ, Cerami A.
    Ann N Y Acad Sci; 1989 Mar; 569():211-8. PubMed ID: 2698089
    [Abstract] [Full Text] [Related]

  • 4. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia.
    Tracey KJ, Morgello S, Koplin B, Fahey TJ, Fox J, Aledo A, Manogue KR, Cerami A.
    J Clin Invest; 1990 Dec; 86(6):2014-24. PubMed ID: 2254457
    [Abstract] [Full Text] [Related]

  • 5. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.
    Fong Y, Tracey KJ, Moldawer LL, Hesse DG, Manogue KB, Kenney JS, Lee AT, Kuo GC, Allison AC, Lowry SF.
    J Exp Med; 1989 Nov 01; 170(5):1627-33. PubMed ID: 2809510
    [Abstract] [Full Text] [Related]

  • 6. Physiological responses to cachectin.
    Tracey KJ, Lowry SF, Cerami A.
    Ciba Found Symp; 1987 Nov 01; 131():88-108. PubMed ID: 2836140
    [Abstract] [Full Text] [Related]

  • 7. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.
    Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A.
    Nature; 1987 Nov 01; 330(6149):662-4. PubMed ID: 3317066
    [Abstract] [Full Text] [Related]

  • 8. Cachectin/tumor necrosis factor and other cytokines in infectious disease.
    Tracey KJ, Cerami A.
    Curr Opin Immunol; 1989 Feb 01; 1(3):454-61. PubMed ID: 2679705
    [Abstract] [Full Text] [Related]

  • 9. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.
    Tracey KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Nguyen HT, Kuo GC, Beutler B, Cotran RS, Cerami A.
    J Exp Med; 1988 Mar 01; 167(3):1211-27. PubMed ID: 3351436
    [Abstract] [Full Text] [Related]

  • 10. Inflammatory cytokines.
    Cerami A.
    Clin Immunol Immunopathol; 1992 Jan 01; 62(1 Pt 2):S3-10. PubMed ID: 1728986
    [Abstract] [Full Text] [Related]

  • 11. Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins.
    Fong Y, Moldawer LL, Marano M, Wei H, Barber A, Manogue K, Tracey KJ, Kuo G, Fischman DA, Cerami A.
    Am J Physiol; 1989 Mar 01; 256(3 Pt 2):R659-65. PubMed ID: 2784290
    [Abstract] [Full Text] [Related]

  • 12. Cachectin/tumor necrosis factor: a possible mediator of cancer anorexia in the rat.
    Stovroff MC, Fraker DL, Swedenborg JA, Norton JA.
    Cancer Res; 1988 Aug 15; 48(16):4567-72. PubMed ID: 3165053
    [Abstract] [Full Text] [Related]

  • 13. Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo.
    Moldawer LL, Marano MA, Wei H, Fong Y, Silen ML, Kuo G, Manogue KR, Vlassara H, Cohen H, Cerami A.
    FASEB J; 1989 Mar 15; 3(5):1637-43. PubMed ID: 2784116
    [Abstract] [Full Text] [Related]

  • 14. Cachectin/tumor necrosis factor and interleukin-1 show different modes of combined effect on lipoprotein lipase activity and intracellular lipolysis in 3T3-L1 cells.
    Ogawa H, Nielsen S, Kawakami M.
    Biochim Biophys Acta; 1989 Jun 08; 1003(2):131-5. PubMed ID: 2786429
    [Abstract] [Full Text] [Related]

  • 15. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T, Baumgartner JD, Glauser MP.
    Prog Clin Biol Res; 1991 Jun 08; 367():141-59. PubMed ID: 1924424
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome.
    Lähdevirta J, Maury CP, Teppo AM, Repo H.
    Am J Med; 1988 Sep 08; 85(3):289-91. PubMed ID: 3414726
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The complex regulation and biology of TNF (cachectin).
    Beutler B.
    Crit Rev Oncog; 1990 Sep 08; 2(1):9-18. PubMed ID: 2091751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.